JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.59% |
| 2 | Technology | 12.2% |
| 3 | Healthcare | 9.44% |
| 4 | Consumer Discretionary | 8.6% |
| 5 | Industrials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3751
Manitowoc
MTW
$702M
| $696K | ﹤0.01% |
17,690
-42,793
| -71% | -$1.65M |
|
3752
Vanguard Tax-Exempt Bond Index Fund
VTEB
$46B
| $696K | ﹤0.01% |
13,475
-944
| -7% | -$48.8K |
|
3753
iShares US Regional Banks ETF
IAT
$682M
| $694K | ﹤0.01% |
14,083
+340
| +2% | +$16.3K |
|
3754
Vanguard Industrials ETF
VIS
$8.49B
| $694K | ﹤0.01% |
4,881
+3,213
| +193% | +$441K |
|
|
CHK
3755
CALL
DELISTED
Chesapeake Energy Corporation
CHK
| $693K | ﹤0.01% |
875
| – | – |
|
3756
CALL
Abbott
ABT
$190B
| $691K | ﹤0.01% |
12,100
| – | – |
|
|
MLPI
3757
DELISTED
UBS E-TRACS Alerian MLP Infrastructure ETN
MLPI
| $691K | ﹤0.01% |
28,549
-102,142
| -78% | -$2.43M |
|
3758
Lesaka Technologies
LSAK
$414M
| $690K | ﹤0.01% |
58,070
+30,467
| +110% | +$309K |
|
3759
Harmonic Inc
HLIT
$1.24B
| $689K | ﹤0.01% |
164,184
+24,296
| +17% | +$91.2K |
|
3760
MarineMax
HZO
$1.16B
| $689K | ﹤0.01% |
+36,463
| New | +$702K |
|
3761
Natera
NTRA
$45.1B
| $687K | ﹤0.01% |
+76,379
| New | +$825K |
|
|
VSI
3762
DELISTED
Vitamin Shoppe Inc.
VSI
| $687K | ﹤0.01% |
156,210
+48,325
| +45% | +$213K |
|
|
3763
PUT
Abbott
ABT
$190B
| $685K | ﹤0.01% |
12,000
| – | – |
|
3764
Autohome
ATHM
$2.65B
| $684K | ﹤0.01% |
10,582
-93,053
| -90% | -$5.62M |
|
|
ARD
3765
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
| $682K | ﹤0.01% |
32,307
-14,817
| -31% | -$305K |
|
3766
SiteOne Landscape Supply
SITE
$4.32B
| $680K | ﹤0.01% |
8,862
-126,238
| -93% | -$8.55M |
|
3767
Comstock Resources
CRK
$4.23B
| $678K | ﹤0.01% |
+80,200
| New | +$476K |
|
|
CLCT
3768
DELISTED
Collectors Universe
CLCT
| $676K | ﹤0.01% |
23,603
+4,484
| +23% | +$120K |
|
3769
CALL
Elevance Health
ELV
$84.7B
| $675K | ﹤0.01% |
3,000
| – | – |
|
3770
Tilly's
TLYS
$127M
| $671K | ﹤0.01% |
45,447
+16,807
| +59% | +$225K |
|
|
AFT
3771
DELISTED
Apollo Senior Floating Rate Fund Inc.
AFT
| $671K | ﹤0.01% |
41,355
+9,360
| +29% | +$154K |
|
|
GSS
3772
DELISTED
Golden Star Resources Ltd.
GSS
| $671K | ﹤0.01% |
150,888
+36,560
| +32% | +$148K |
|
|
CARB
3773
DELISTED
Carbonite Inc
CARB
| $670K | ﹤0.01% |
26,675
+23,175
| +662% | +$538K |
|
3774
Voyager Therapeutics
VYGR
$197M
| $669K | ﹤0.01% |
40,328
+26,499
| +192% | +$454K |
|
|
PVLA
3775
Palvella Therapeutics
PVLA
$2.22B
| $668K | ﹤0.01% |
1,106
-170
| -13% | -$79K |
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 811 new, 2,514 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 811 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.